Burden of Middle‐Aged and Elderly Patients With Non‐Hodgkin Lymphoma From 1990 to 2021: A Systematic Analysis Based on the Global Burden of Disease 2021
Cancer Medicine · 2026
DOI: 10.1002/cam4.71609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Yuecan Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Lymphoma, Non-Hodgkin, Global Burden of Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Non‐Hodgkin lymphoma (NHL) is increasingly prevalent in middle‐aged and elderly populations, contributing to the rising global health burden, particularly in high‐income countries.
Methods
This retrospective analysis utilized data from the Global Burden of Disease (GBD) study (1990–2021) to examine temporal trends in age‐standardized incidence, mortality, and disability‐adjusted life year (DALY) rates of NHL among middle‐aged and older adult populations, incorporating age‐ and sex‐stratified comparisons. Furthermore, projections for the subsequent 30 years were generated using Bayesian age‐period‐cohort (BAPC) modeling.
Results
From 1990 to 2021, the number of cases, deaths, and DALYs in middle‐aged and older people with NHL had significant increases. Age‐standardized incidence rates exhibited an increasing trend (estimated annual percentage change [EAPC] = 0.53), whereas mortality (EAPC = −0.33) and DALY rates (EAPC = −0.52) demonstrated a decreasing trend. The Western European region and high SDI countries are the core burden areas for middle‐aged and elderly populations with NHL globally. Lower‐middle SDI countries experienced the fastest increase in mortality (EAPC = 0.38) and DALY rates (EAPC = 0.22), while high‐SDI countries experienced the steepest decline in all metrics. The DALY burden showed its peak value at 65–69 years among middle‐aged and aged adults with NHL, while the morbidity and mortality burden reached their highest point at 70–74 years. When stratified by gender, the overall burden was higher in males than in females. High BMI causes the burden of NHL DALY to rise with increasing SDI, up to 39.14% in High‐income North America. By 2050, global NHL incidence is projected to increase modestly by 0.28%, whereas mortality and DALY burdens are expected to decline markedly by 30.67% and 23.02%, respectively.
Conclusions
NHL in middle‐aged and older adults represents a significant global public health burden, necessitating context‐specific interventions due to variations across regions, genders, and age groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
- Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
- School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
ORCID-Profile: Haiyan Lang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Jiang, Y., Xu, Y., Ma, Y., Yao, W., Cao, Q., Zhang, X., Peng, L., Tang, Y., Cheng, Y., Ren, R., Chen, X., & Lang, H. (2026). Burden of Middle‐Aged and Elderly Patients With Non‐Hodgkin Lymphoma From 1990 to 2021: A Systematic Analysis Based on the Global Burden of Disease 2021. Cancer Medicine. https://doi.org/10.1002/cam4.71609
Vancouver
Chen Y, Jiang Y, Xu Y, Ma Y, Yao W, Cao Q, et al. Burden of Middle‐Aged and Elderly Patients With Non‐Hodgkin Lymphoma From 1990 to 2021: A Systematic Analysis Based on the Global Burden of Disease 2021. Cancer Medicine. 2026. doi:10.1002/cam4.71609
BibTeX
@article{Chen2026,
author = {Chen, Yuecan and Jiang, Yanjie and Xu, Yehan and Ma, Yucao and Yao, Wenjing and Cao, Qinhan and Zhang, Xin and Peng, Liyuan and Tang, Yaling and Cheng, Yuxin and Ren, Ruhua and Chen, Xinyi and Lang, Haiyan},
title = {Burden of Middle‐Aged and Elderly Patients With Non‐Hodgkin Lymphoma From 1990 to 2021: A Systematic Analysis Based on the Global Burden of Disease 2021},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71609}
}
EUVIMED